health

Científicos de la Universidad de Tokio desarrollan vacuna contra el virus Nipah

Caracas, 31 Ene. AVN.- Científicos del Centro de Investigación de Ciencia y Tecnología Avanzadas de la Universidad de Tokio han desarrollado una vacuna basada en el virus del sarampión que se espera sea eficaz contra el virus Nipah, informó el periódico Nikkei, cita despacho de TASS.

Científicos de la Universidad de Tokio desarrollan vacuna contra el virus Nipah

TL;DR

  • A new vaccine developed by the University of Tokyo uses the measles virus to fight the Nipah virus.
  • The vaccine is designed to stimulate the immune system to produce proteins similar to the Nipah virus.
  • The vaccine has shown effectiveness and safety in animal trials.
  • Human clinical trials are scheduled to begin in Belgium in April.
  • Further trials in adults and children are planned for Bangladesh in the second half of 2027.
  • The Nipah virus is a rare zoonotic pathogen with a high fatality rate (40-75%) and no existing vaccines or specific treatments.
  • The UN assesses the risk of Nipah virus expansion in Asia as low, but the subnational public health risk as moderate.

Continuar leyendo el artículo original